Home › Markets › Health Care › CNTN

Canton Strategic Holdings Inc. (CNTN)

CNTN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$2.02
-4.26% on the day
Market cap
$161.0M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerCNTN on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2022
SEC CIK0001861657
SEC industry codeFinance Services
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-03-03
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-08-14
Latest current report8-K2026-08-14
Latest proxyDEF 14A2026-06-25

Source: SEC EDGAR submissions feed, 307 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
DERMJourney Medical Corporation$5.68-3.89%$160.3M
ADAGAdagene Inc.$2.46-10.22%$162.5M
ORGOOrganogenesis Holdings Inc.$1.21-1.63%$155.7M
MENSJyong Biotech Ltd.$2.04-2.86%$155.1M
VRXAVeraxa Biotech AG$1.20+5.26%$169.7M
WHWKWhitehawk Therapeutics Inc.$3.02-10.65%$172.2M
NKTXNkarta Inc.$2.10-3.23%$150.4M
YARWYarrow Bioscience Inc.$18.60-6.16%$173.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier